Biocryst Pharmaceuticals Inc SEC filings BCRX
Biocryst Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to Mar 8, 2016. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K/A |
Amended current report
Exit or restructuring costs
|
Aug 4, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Jun 29, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2026 | Jun 11, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 4, 2026 | May 4, 2026 |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 11, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Jan 23, 2026 | Oct 14, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Regulation FD disclosure
|
Jan 23, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2026 | Jan 9, 2026 |
| EFFECT | Filing | Dec 18, 2025 | — |
| 424B3 | Prospectus | Dec 18, 2025 | — |
| CORRESP | Letter to the SEC | Dec 16, 2025 | — |
| S-4/A | Filing | Dec 15, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 12, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 11, 2025 | Dec 9, 2025 |
| 425 | Filing | Dec 3, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 3, 2025 | Dec 3, 2025 |
| S-4 | Registration for a merger or exchange | Nov 20, 2025 | — |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2025 | Nov 3, 2025 |
| 425 | Filing | Oct 14, 2025 | — |
| 425 | Filing | Oct 14, 2025 | — |
| 425 | Filing | Oct 14, 2025 | — |
| 425 | Filing | Oct 14, 2025 | — |
| 8-K |
Current report
Material agreement, Results of operations, Officer or director change, Other events
|
Oct 14, 2025 | Oct 14, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 1, 2025 | Oct 1, 2025 |
| S-8 | Employee stock plan registration | Aug 12, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Aug 11, 2025 | Aug 11, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 31, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 7, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Material agreement
|
Jun 30, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Other events
|
Jun 27, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Other events
|
Jun 25, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 16, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 4, 2025 | May 31, 2025 |
| 8-K |
Current report
Other events
|
May 14, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 5, 2025 | May 5, 2025 |
| 8-K |
Current report
Officer or director change
|
May 1, 2025 | Apr 30, 2025 |
| ARS | Annual report to shareholders | Apr 24, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 24, 2025 | — |
| DEF 14A | Proxy statement | Apr 24, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2025 | Apr 6, 2025 |
| 8-K |
Current report
Other events
|
Mar 11, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2025 | Feb 28, 2025 |
| 10-K | Annual report | Feb 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Feb 24, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2025 | Jan 8, 2025 |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 2, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2024 | Sep 30, 2024 |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2024 | Jun 12, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2024 | May 6, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 12, 2024 |
| S-3ASR | Automatic shelf registration | Feb 27, 2024 | — |
| 10-K | Annual report | Feb 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 26, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 18, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 1, 2023 | Nov 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 30, 2023 | Nov 30, 2023 |
| S-8 | Employee stock plan registration | Nov 8, 2023 | — |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2023 | Nov 3, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2023 | Nov 3, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 26, 2023 | Oct 26, 2023 |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 11, 2023 | Jul 7, 2023 |
| S-8 | Employee stock plan registration | Jun 30, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 14, 2023 | Jun 13, 2023 |
| 10-Q | Quarterly report | May 8, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 3, 2023 | May 3, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Apr 18, 2023 | Apr 17, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| 10-K | Annual report | Feb 27, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 21, 2023 | Feb 21, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 15, 2022 | Dec 15, 2022 |
| 10-Q | Quarterly report | Nov 4, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 1, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 14, 2022 | Sep 9, 2022 |
| S-8 | Employee stock plan registration | Aug 31, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 25, 2022 | Aug 25, 2022 |
| 10-Q | Quarterly report | Aug 5, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2022 | Aug 4, 2022 |
| S-8 | Employee stock plan registration | Jul 14, 2022 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2022 | Jun 7, 2022 |
| DEFA14A | Additional proxy material | May 26, 2022 | — |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 5, 2022 | May 5, 2022 |
| DEFA14A | Additional proxy material | Apr 25, 2022 | — |
| DEF 14A | Proxy statement | Apr 25, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 11, 2022 | Apr 8, 2022 |
| 8-K |
Current report
Other events
|
Apr 8, 2022 | Apr 8, 2022 |
| 10-K | Annual report | Feb 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 23, 2022 | Feb 23, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 22, 2022 | Feb 22, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 17, 2022 | Feb 17, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 8, 2022 | Feb 4, 2022 |
| UPLOAD | Letter from the SEC | Jan 18, 2022 | — |
| CORRESP | Letter to the SEC | Jan 14, 2022 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2022 | Jan 7, 2022 |
| UPLOAD | Letter from the SEC | Dec 14, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 29, 2021 | Nov 29, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Nov 22, 2021 | Nov 19, 2021 |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2021 | Nov 3, 2021 |
| S-8 | Employee stock plan registration | Sep 30, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2021 | Sep 15, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 1, 2021 | Aug 27, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 26, 2021 | Aug 24, 2021 |
| 424B5 | Prospectus supplement | Aug 9, 2021 | — |
| 10-Q | Quarterly report | Aug 9, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 9, 2021 | Aug 8, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 3, 2021 | Jul 28, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 28, 2021 | Jul 26, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2021 | Jun 3, 2021 |
| S-8 | Employee stock plan registration | May 28, 2021 | — |
| S-8 | Employee stock plan registration | May 28, 2021 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 26, 2021 | May 25, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
May 12, 2021 | May 12, 2021 |
| 10-Q | Quarterly report | May 7, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 30, 2021 | Apr 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 14, 2021 | Apr 14, 2021 |
| DEFA14A | Additional proxy material | Apr 13, 2021 | — |
| DEF 14A | Proxy statement | Apr 13, 2021 | May 25, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 26, 2021 | Mar 26, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 22, 2021 | Mar 22, 2021 |
| SEC STAFF LETTER | Filing | Mar 22, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 18, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2021 | Mar 2, 2021 |
| S-3ASR | Automatic shelf registration | Mar 1, 2021 | — |
| 10-K | Annual report | Mar 1, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 25, 2021 | Feb 25, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 25, 2021 | Feb 25, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 3, 2021 | Feb 3, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 22, 2021 | Jan 22, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 22, 2020 | Dec 22, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 22, 2020 | Dec 22, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 21, 2020 | Dec 21, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 17, 2020 | Dec 16, 2020 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Dec 7, 2020 | Dec 7, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 4, 2020 | Dec 3, 2020 |
| 10-Q | Quarterly report | Nov 6, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 3, 2020 | Aug 31, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 31, 2020 | Aug 31, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 31, 2020 | Aug 31, 2020 |
| S-8 | Employee stock plan registration | Aug 12, 2020 | — |
| 10-Q | Quarterly report | Aug 7, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 3, 2020 | Aug 3, 2020 |
| S-8 | Employee stock plan registration | Jun 10, 2020 | — |
| S-8 | Employee stock plan registration | Jun 10, 2020 | — |
| S-8 | Employee stock plan registration | Jun 10, 2020 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jun 1, 2020 | Jun 1, 2020 |
| 424B2 | Prospectus | May 29, 2020 | — |
| 424B5 | Prospectus supplement | May 27, 2020 | — |
| EFFECT | Filing | May 14, 2020 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
May 13, 2020 | May 12, 2020 |
| CORRESP | Letter to the SEC | May 12, 2020 | — |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2020 | May 6, 2020 |
| CORRESP | Letter to the SEC | May 4, 2020 | — |
| CT ORDER | Filing | May 1, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2020 | — |
| S-3 | Shelf registration | Apr 24, 2020 | — |
| 8-K |
Current report
Other events
|
Apr 10, 2020 | Apr 9, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 2, 2020 | Apr 2, 2020 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BCRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Large accelerated filer
- SEC CIK
- 882796
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.